PharmiWeb1d
The Rise of DNA Sequencing: Innovations Shaping the Market
The DNA Sequencing Industry has rapidly transformed into one of the most crucial areas of biotechnology. What was once a time ...
New Food Magazine3d
Contamination recalls cost money
Edward Haynes reveals how advanced sequencing technologies are assisting food companies in their mission to deliver quality ...
manilatimes1d
Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), ...
TMCnet19h
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and ...
PharmiWeb4d
Whole Genome Amplification Market Set to Reach Over USD 6.5 Million by 2034 at a 8.1% of CAGR
Whole Genome Amplification MarketThe global whole genome amplification (WGA) market is on track for substantial growth, with projections indicating that it will exceed USD 6.5 million by 2034. In 2024 ...
Blood immune cells found to impact cancer survival
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
F. Hoffmann-La Roche Ltd: Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, immun ...
Researchers investigate rare side effect of blood cancer immunotherapy
Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...
GeneDx targets $350M-$360M revenue for 2025 with 30% growth in exome and genome testing
President and CEO Katherine Stueland stated that GeneDx achieved significant milestones in 2024, including surpassing $95 million in Q4 revenue and expanding gross margins to 70%. She highlighted the ...